Segment Information - Segment Revenue, Operating Income (Loss) and Depreciation and Amortization (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information [Line Items]
Revenue	$ 31,958	$ 27,198	$ 62,510	$ 52,131
Total operating income (loss)	659	(6,583)	337	(13,812)
Depreciation and amortization	2,096	2,092	4,429	4,214
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	31,958	27,198	62,510	52,131
Total operating income (loss)	3,658	(3,423)	6,558	(7,710)
Operating Segments [Member] | Medical Device [Member]
Segment Reporting Information [Line Items]
Revenue	24,826	19,707	48,371	38,725
Total operating income (loss)	302	(7,059)	78	(14,294)
Depreciation and amortization	1,916	1,933	3,970	3,886
Operating Segments [Member] | In Vitro Diagnostics [Member]
Segment Reporting Information [Line Items]
Revenue	7,132	7,491	14,139	13,406
Total operating income (loss)	3,356	3,636	6,480	6,584
Depreciation and amortization	96	75	193	152
Corporate Non Segment [Member]
Segment Reporting Information [Line Items]
Total operating income (loss)	(2,999)	(3,160)	(6,221)	(6,102)
Depreciation and amortization	$ 84	$ 84	$ 266	$ 176